§ 69.04.510. Drugs -- Misbranding for improper packaging and labeling
A drug or device shall be deemed to be misbranded if it purports to be a drug the name of which is recognized in an official compendium, unless it is packaged and labeled as prescribed therein: PROVIDED, That the method of packing may be modified with the consent of the director, as permitted under section 502(g) of the federal act. Whenever a drug is recognized in both the United States pharmacopoeia and the homeopathic pharmacopoeia of the United States, it shall be subject to the requirements of the United States pharmacopoeia with respect to packaging and labeling unless it is labeled and offered for sale as a homeopathic drug, in which case it shall be subject to the provisions of the homeopathic pharmacopoeia of the United States, and not to those of the United States pharmacopoeia.
[1945 c 257 § 69; Rem. Supp. 1945 § 6163-118. Prior: 1923 c 36 § 2; 1907 c 211 § 4.]
Sections: Previous 69.04.440 69.04.450 69.04.460 69.04.470 69.04.480 69.04.490 69.04.500 69.04.510 69.04.520 69.04.530 69.04.540 69.04.550 69.04.560 69.04.565 69.04.570 NextLast modified: April 7, 2009